5 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds

2. Pfizer Inc. (NYSE:PFE)

Number of Hedge Fund Holders: 75

Pfizer Inc. (NYSE:PFE) remains one of the most favorite healthcare stocks among the elite hedge funds in financial markets. Pfizer Inc. (NYSE:PFE) is moving beyond just the COVID-19 vaccines as the company has much to offer in terms of its pipeline to long-term investors. Recently, Pfizer Inc. (NYSE:PFE) announced that the FDA accepted its Biologics License Application (BLA) for its respiratory syncytial virus (RSV) vaccine candidate PF-06928316 for priority review. The treatment targets pregnant women for the prevention of RSV in infants.

As of the end of the fourth quarter of 2022, 75 hedge funds tracked by Insider Monkey reported owning stakes in Pfizer Inc. (NYSE:PFE). The net worth of these stakes was about $2.5 billion.

Diamond Hill Capital made the following comment about Pfizer Inc. (NYSE:PFE) in its Q3 2022 investor letter:

“Also among our bottom contributors were health care products manufacturer Abbott Labs, global pharmaceutical company Pfizer Inc. (NYSE:PFE), media and technology giant Alphabet, and insurance company American International Group (AIG). Although Pfizer continues to report strong performance of its core drugs, sales of its COVID vaccine and treatment have likely peaked and sales are expected to decline going forward. We remain optimistic about the company long term as we believe management is taking the company in the right direction, focusing R&D, and making strategic acquisitions with profits generated from COVID vaccine sales.”